Emcure Pharmaceuticals share price
You have to be logged in to add this to Watchlist.- ₹1,734.25(3.07%)June 12, 2026 15:44:54 PM IST
- NSE
- BSE
- Vol : 118.72 K (NSE + BSE)Last 20 day avg : 157.75 K
Emcure Pharmaceuticals is trading 3.07% upper at Rs 1,734.25 as compared to its last closing price. Emcure Pharmaceuticals has been trading in the price range of 1,745.00 & 1,678.50. Emcure Pharmaceuticals has given 23.36% in this year & -3.55% in the last 5 days. Emcure Pharmaceuticals has TTM P/E ratio 32.71 as compared to the sector P/E of 26.87.There are 6 analysts who have initiated coverage on Emcure Pharmaceuticals. There are 5 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 243.40 Crores in its last quarter.Listed peers of Emcure Pharmaceuticals include Divi's Laboratories (-0.34%), Sun Pharmaceutical Industries (0.72%), Dr Reddy's Laboratories (-0.10%).The Mutual Fund holding in Emcure Pharmaceuticals was at 4.94% in 31 Mar 2026. The MF holding has increased from the last quarter. The FII holding in Emcure Pharmaceuticals was at 3.35% in 31 Mar 2026. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jun 13, 2026, 07:11 PM UTC
- Debt To EquityHigher than industry0.31The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.21Annual dividends as a percentage of the stock price.
- PEG RatioIndicates Fair Valuation1.71The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Divi's Laboratories | Bullish | 6,628.80 | -0.34 | 1,75,426.53 | 78.61 | 11.52 | 0.46 | 0.01 |
| Sun Pharmaceutical Industries | Bullish | 1,807.25 | 0.72 | 4,32,524.85 | 36.24 | 5.77 | 0.92 | 0.50 |
| Dr Reddy's Laboratories | Neutral | 1,273.80 | -0.10 | 1,06,313.63 | 18.63 | 3.14 | 0.63 | 2.34 |
| Cipla | Moderately Bullish | 1,388.80 | 0.42 | 1,12,187.34 | 22.95 | 3.87 | 0.87 | 0.81 |
| Torrent Pharmaceuticals | Bullish | 4,577.00 | 0.15 | 1,54,232.03 | 67.32 | 17.1 | 0.83 | 17.62 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-05-05 | Audited Results & Final Dividend |
| 2026-02-04 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
- IndustryBiotechnology & Drugs
- ISININE168P01015
- BSE Code544210
- NSE CodeEMCURE
Emcure Pharmaceuticals is trading at 1734.25 as on Fri Jun 12 2026 10:14:54. This is 3.07% upper as compared to its previous closing price of 1682.60.
The market capitalization of Emcure Pharmaceuticals is 32891.71 Cr as on Fri Jun 12 2026 10:14:54.
The average broker rating on Emcure Pharmaceuticals is Strong Buy. The breakup of analyst rating is given below -
- 5 analysts have given a strong buy rating
- 0.00 analysts have given a buy rating
- 1 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Emcure Pharmaceuticals is 1830.35 whereas the 52 wk low is 1230.00
Emcure Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 32.71
- Sector P/E: 26.87
- Dividend Yield: 0.21%
- D/E ratio: 0.31
Emcure Pharmaceuticals reported a net profit of 924.36 Cr in 2026.
The Mutual Fund Shareholding was 4.94% at the end of 31 Mar 2026.
EQUITY QUICK LINKS
Emcure Pharmaceuticals QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.